Westpac Banking Corp Has $6,014,000 Stake in Amdocs Ltd. (DOX)
Westpac Banking Corp held its position in Amdocs Ltd. (NASDAQ:DOX) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 104,200 shares of the company’s stock at the end of the second quarter. Westpac Banking Corp owned about 0.07% of Amdocs worth $6,014,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DOX. Panagora Asset Management Inc. boosted its stake in Amdocs by 4.7% in the first quarter. Panagora Asset Management Inc. now owns 890,357 shares of the company’s stock worth $53,795,000 after buying an additional 40,151 shares in the last quarter. BNP Paribas Arbitrage SA boosted its stake in Amdocs by 0.6% in the second quarter. BNP Paribas Arbitrage SA now owns 29,796 shares of the company’s stock worth $1,720,000 after buying an additional 184 shares in the last quarter. State Street Corp boosted its stake in Amdocs by 2.8% in the first quarter. State Street Corp now owns 1,995,422 shares of the company’s stock worth $120,562,000 after buying an additional 53,565 shares in the last quarter. BlackRock Group LTD boosted its stake in Amdocs by 4.5% in the first quarter. BlackRock Group LTD now owns 911,307 shares of the company’s stock worth $55,060,000 after buying an additional 39,250 shares in the last quarter. Finally, Calvert Investment Management Inc. boosted its stake in Amdocs by 3.9% in the second quarter. Calvert Investment Management Inc. now owns 8,304 shares of the company’s stock worth $479,000 after buying an additional 315 shares in the last quarter. 89.63% of the stock is owned by institutional investors.
Amdocs Ltd. (NASDAQ:DOX) opened at 59.5825 on Tuesday. Amdocs Ltd. has a 12-month low of $50.06 and a 12-month high of $61.33. The firm has a market capitalization of $8.87 billion, a price-to-earnings ratio of 22.5265 and a beta of 0.68. The firm has a 50-day moving average of $59.52 and a 200 day moving average of $58.18.
Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, July 26th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.87 by $0.03. The business earned $930 million during the quarter, compared to the consensus estimate of $928.81 million. Amdocs had a net margin of 10.93% and a return on equity of 14.59%. The business’s revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.84 EPS. On average, equities analysts predict that Amdocs Ltd. will post $3.57 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 21st. Stockholders of record on Friday, September 30th will be issued a $0.195 dividend. The ex-dividend date is Wednesday, September 28th. This represents a $0.78 dividend on an annualized basis and a dividend yield of 1.31%. Amdocs’s dividend payout ratio is presently 29.32%.
A number of equities analysts recently weighed in on the stock. Jefferies Group boosted their price target on shares of Amdocs from $56.00 to $58.00 and gave the stock a “hold” rating in a research report on Tuesday, August 2nd. Oppenheimer Holdings Inc. restated an “outperform” rating and set a $65.00 price target on shares of Amdocs in a research report on Thursday, September 15th. Citigroup Inc. boosted their price target on shares of Amdocs from $63.00 to $66.00 and gave the stock a “buy” rating in a research report on Wednesday, July 27th. Zacks Investment Research lowered shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Monday, July 11th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Amdocs from $61.00 to $64.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 27th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Amdocs has a consensus rating of “Buy” and a consensus target price of $63.13.
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Ltd. (NASDAQ:DOX).
Receive News & Ratings for Amdocs Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.